←Back to Expert Scholars
Translational Medicine / 转化医学Breast Cancer in Older Adults
Rachel Freedman
MD, MPH
🏢Dana-Farber Cancer Institute🌐USA
Institute Physician, Breast Oncology Center
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rachel Freedman focuses on breast cancer in older adults and rare breast cancer subtypes and has led trials of HER2 targeted therapies including tucatinib. She is a clinical investigator at Dana-Farber focused on underrepresented breast populations.
Share:
🧪Research Fields 研究领域
older adults breast cancer
phyllodes tumor
tucatinib HER2
rare breast cancer trials
geriatric oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rachel Freedman 的研究动态
Follow Rachel Freedman's research updates
留下邮箱，当我们发布与 Rachel Freedman（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment